Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
DEEPAKNTR
Mr. Maulik Deepak Mehta · Vadodara, India · 1,447 employees
₹1,674.60
▲+1.41%DEEPAKNTR's stock has surged 1.41% on the back of sustained revenue growth and declining debt levels, but faces stiff competition in the chemicals sector.
Exchange
NSI
Currency
INR
Day range
₹1,652.20 – ₹1,686.30
52-week range
₹1,280.00 – ₹1,916.70
Sector
Basic Materials
Industry
Chemicals
AI investment rating
AI analysis50% confidence
We believe DEEPAKNTR's current price of 1674.6 INR reflects a slightly optimistic view on its growth prospects, trading in the upper third of its 1-year range.
12.6% below the 1-year high · trend up
Hedge-fund memo
Today
1.41% price gain amidst low trading volume, possibly driven by short-term momentum or positioning.
This week
Stock price remains within the upper third of its 1-year range, with 52-week highs indicating ongoing interest in the company.
This month
Price action has been volatile over the past few months, with a general uptrend observed.
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Neutral
2 headlines · 2 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 2 of 4 recent quarters (EPS actual vs. consensus).
16.11 vs 11.84
36.06% surprise
8.0014 vs 9.1
-12.07% surprise
8.71 vs 8.2
6.22% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| DEEPAKNTR | 228.40B | 41.56 | 9.75% | 15.56% | -2.70% |
| NAVINFLUOR | 389.60B | 58.10 | 20.10% | 31.09% | 33.80% |
| ALKYLAMINE | 92.95B | 51.72 |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 499sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Supply Chain Risk
Mitigation: Diversification of suppliers and strengthening relationships with key vendors could help mitigate this risk.
Intense Competition
Mitigation: Investment in product development and R&D to maintain market share and stay competitive.
Business intelligence
Competitive moat
The company's diversified product range, strong relationships with key customers, and ongoing R&D investments give Deepak Nitrite a competitive edge in the chemicals sector.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Positive developments in the Pharmaceuticals sector or significant growth in domestic API demand.
Thesis builder
Bull case
The Indian government's push for self-sufficiency in Pharmaceuticals and the growth in Domestic API demand could drive up revenue and profits.
Base case
Conservative estimate of 10% revenue growth for the next 2-3 years, driven by moderate expansion of the Indian Pharmaceuticals market.
Bear case
Stiff competition and potential disruptions to supply chains due to international conflicts or logistics issues could dent revenues and profitability.
Time horizon
Medium-term (2-5 years) view.
Est. CAGR
10-15%
Entry (qual.)
Entry when the stock price shows clear signs of consolidation or stabilization, with fundamentals indicating growth and competitiveness.
Exit (qual.)
Sell when revenue growth stalls, or signs of decreased demand emerge.
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how DEEPAKNTR fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain DEEPAKNTR for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
—
Wait for a pullback or stabilization in the stock price before reassessing its potential for future growth.
equitypandit.com·6d ago·near term outlook unclear
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
8.23 vs 11.64286
-29.31% surprise
| — |
| 13.98% |
| -4.60% |
| AARTIIND | 176.10B | 42.07 | 7.25% | 9.84% | 13.20% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹1,652.20
Resistance (day/52w high)
₹1,686.30
Volume
54,921
Trend
up
RSI (14)
50
MACD
bearish
MA cross
golden
50-day MA
₹1,662.27
200-day MA
₹1,622.82
vs 200-DMA
3.2%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.
Overall conviction 50%